LexDanaLexDanabeta
Inventor

Anne RIETZ

Inventor
US

Overview

3→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
PatentTitleYear
12,583,850Small molecule antiviral drug treatment for human papillomavirus infections202612,533,339Small molecule antiviral drug treatment for human papillomavirus infections202611,877,999Small molecule antiviral drug treatment for human papillomavirus infections2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2026Patents assigned to KOVINA THERAPEUTICS INC (3)· patent assignee history
2024–2026Patents assigned to UNIV INDIANA TRUSTEES (3)· patent assignee history
2024–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KOVINA THERAPEUTICS INC32024–2026
UNIV INDIANA TRUSTEES32024–2026
Locations
LocationPatentsSpan
US32024–2026